Literature DB >> 16443085

Risk factors for ICU-acquired methicillin-resistant Staphylococcus aureus infections.

Nefise Oztoprak1, Mustafa Aydin Cevik, Esragul Akinci, Munire Korkmaz, Ayse Erbay, Selim Sirri Eren, Neriman Balaban, Hurrem Bodur.   

Abstract

BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial pathogen that causes severe morbidity and mortality in many hospitals worldwide, and MRSA infections are frequent in intensive care units (ICUs).
OBJECTIVE: A prospective study was implemented to investigate the risk factors for ICU-acquired MRSA infections.
METHODS: This study was conducted in surgical and neurologic ICUs from May to November 2003. The patients staying in ICUs more than 48 hours were included in the study. All of the patients were visited daily, and data were recorded on individual forms for each patient until discharge or death. Nasal swab cultures were done within 48 hours of ICU admission and repeated every week until the patients colonized with MRSA or were discharged from ICUs. ICU-acquired MRSA infection was diagnosed when MRSA was isolated from the infected site.
RESULTS: Overall, 249 patients were followed during the study. MRSA infection was detected in 21 (8.4%) of these patients. The most frequent infection was primary bloodstream infection (10/21, 47%). It was followed by pneumonia (8/21, 38%) and surgical site infection (3/21, 14%). Nasal MRSA colonization was detected in 59 (23.7%) patients, and 12 of them (20.3%) developed MRSA infection. In univariate analysis, hospitalization period in an ICU, intraabdominal and orthopedic pathologies, mechanical ventilation, central venous catheter insertion, total parenteral nutrition, previous antibiotic use, surgical ICU stay, nasal MRSA colonization, and presence of more than 2 patients having nasal colonization in the same ICU at the same time were found significant for MRSA infections. In multivariate analysis; hospitalization period in an ICU (OR, 1.090; 95% CI: 1.038-1.144, P = .001), central venous catheter insertion (OR, 1.822; 95% CI: 1.095-3.033, P = .021), previous antibiotic use (OR, 2.337; 95% CI: 1.326-4.119, P = .003) and presence of more than 2 patients having nasal colonization in the same ICU at the same time (OR, 1.398; 95% CI: 1.020-1.917, P = .037) were independently associated with MRSA infections.
CONCLUSION: According to the our results, hospitalization period in an ICU, presence of patients colonized with MRSA in the same ICU at the same time, previous antibiotic use, and central venous catheter insertion are independent risk factors for ICU-acquired MRSA infections. Detection of these factors helps to decrease the rate of MRSA infections in the ICUs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16443085     DOI: 10.1016/j.ajic.2005.07.005

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  19 in total

Review 1.  Airborne transmission of disease in hospitals.

Authors:  I Eames; J W Tang; Y Li; P Wilson
Journal:  J R Soc Interface       Date:  2009-10-14       Impact factor: 4.118

Review 2.  Methicillin-resistant Staphylococcus aureus (MRSA): antibiotic-resistance and the biofilm phenotype.

Authors:  Kelly M Craft; Johny M Nguyen; Lawrence J Berg; Steven D Townsend
Journal:  Medchemcomm       Date:  2019-03-14       Impact factor: 3.597

3.  Staphylococcus aureus nasal colonization and subsequent infection in intensive care unit patients: does methicillin resistance matter?

Authors:  Hitoshi Honda; Melissa J Krauss; Craig M Coopersmith; Marin H Kollef; Amy M Richmond; Victoria J Fraser; David K Warren
Journal:  Infect Control Hosp Epidemiol       Date:  2010-06       Impact factor: 3.254

4.  Characterization of the best anatomical sites in screening for methicillin-resistant Staphylococcus aureus colonization.

Authors:  Y Bitterman; A Laor; S Itzhaki; G Weber
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-01-29       Impact factor: 3.267

5.  Modeling risk for developing drug resistant bacterial infections in an MDR-naive critically ill population.

Authors:  Rajiv Sonti; Megan E Conroy; Elena M Welt; Yi Hu; George Luta; Daniel B Jamieson
Journal:  Ther Adv Infect Dis       Date:  2017-07-05

6.  Staphylococcal enterotoxin P predicts bacteremia in hospitalized patients colonized with methicillin-resistant Staphylococcus aureus.

Authors:  Michael S Calderwood; Christopher A Desjardins; George Sakoulas; Robert Nicol; Andrea Dubois; Mary L Delaney; Ken Kleinman; Lisa A Cosimi; Michael Feldgarden; Andrew B Onderdonk; Bruce W Birren; Richard Platt; Susan S Huang
Journal:  J Infect Dis       Date:  2013-09-16       Impact factor: 5.226

7.  MRSA detection: comparison of two molecular methods (BD GeneOhm PCR assay and Easy-Plex) with two selective MRSA agars (MRSA-ID and Oxoid MRSA) for nasal swabs.

Authors:  S J van Hal; Z Jennings; D Stark; D Marriott; J Harkness
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-29       Impact factor: 3.267

8.  Methicillin-resistant Staphylococcus aureus nosocomial infection trends in Hospital Universiti Sains Malaysia during 2002-2007.

Authors:  Hassanain I Al-Talib; Chan Y Yean; Karim Al-Jashamy; Habsah Hasan
Journal:  Ann Saudi Med       Date:  2010 Sep-Oct       Impact factor: 1.526

Review 9.  Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology.

Authors:  Sahreena Lakhundi; Kunyan Zhang
Journal:  Clin Microbiol Rev       Date:  2018-09-12       Impact factor: 26.132

10.  Ward-level factors associated with methicillin-resistant Staphylococcus aureus acquisition-an electronic medical records study in Singapore.

Authors:  Zaw Myo Tun; Dale A Fisher; Sharon Salmon; Clarence C Tam
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.